Global Legal Chronicle: GreenLight Biosciences Holdings’ Go-Private Transaction
June 1, 2023
O’Melveny advised Fall Line Endurance Fund, L.P., a private equity firm uniquely focused on investments in US farmland, active management of farmland, and AgTech startups, as the lead investor in a consortium that has agreed to acquire and take-private Greenlight Biosciences (NASDAQ: GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address issues in human health and agriculture, for US$0.30 per share, net of cash. The transaction was announced on May 30 and is expected to close in the third quarter of 2023, subject to customary closing conditions. The O’Melveny team was led by M&A partners Nate Gallon and Noah Kornblith, counsel Christopher Cash, and associates Christian Coyne, Kevin Togami, and Christina Meng.
Read the full article here.